The agency’s safety monitoring plan outlines how information that emerges after the authorization of COVID-19 vaccines will be collected and reviewed. The European Medicines Agency (EMA) announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback